Clinical trial

Regimen Transition After Short-Term Intensive Insulin Therapy in Type 2 Diabetes

NCT07173712

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2026-03-15

PhasePHASE4

Study timeline

Study start (estimated)2026-03-15Date precision: day

Registry last updated2026-02-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetesunresolved

Interventions

CSIIDRUG

Insulin glargine /lixisenatide Fixed Ratio CombinationDRUG

Insulin Degludec and Insulin Aspart InjectionDRUG

Insulin Glargine (HOE901 - U300)DRUG

MetforminDRUG · verified · RxNorm: metformin

Sponsors & collaborators

Yanbing Lilead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07173712 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.